These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9210691)

  • 21. Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis.
    Graybill JR; Bocanegra R; Lambros C; Luther MF
    J Med Vet Mycol; 1997; 35(4):243-7. PubMed ID: 9292420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.
    Mayanja-Kizza H; Oishi K; Mitarai S; Yamashita H; Nalongo K; Watanabe K; Izumi T; Ococi-Jungala ; Augustine K; Mugerwa R; Nagatake T; Matsumoto K
    Clin Infect Dis; 1998 Jun; 26(6):1362-6. PubMed ID: 9636863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.
    Larsen RA; Bozzette SA; Jones BE; Haghighat D; Leal MA; Forthal D; Bauer M; Tilles JG; McCutchan JA; Leedom JM
    Clin Infect Dis; 1994 Oct; 19(4):741-5. PubMed ID: 7803641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
    Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of D0870 and fluconazole in the treatment of murine cryptococcal meningitis.
    Correa AL; Velez G; Albert M; Luther M; Rinaldi MG; Graybill JR
    J Med Vet Mycol; 1995; 33(6):367-74. PubMed ID: 8683404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal therapy for treatment of cryptococcal meningitis.
    Yao Z; Liao W; Wen H
    Chin Med J (Engl); 2000 Feb; 113(2):178-80. PubMed ID: 11775548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Najvar LK; Bocanegra R; Caselli F; Di Cesare S; Giannini D; Di Francesco LF; Giacometti A; Carle F; Scalise G; Graybill JR
    Antimicrob Agents Chemother; 2001 May; 45(5):1355-9. PubMed ID: 11302795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
    mBio; 2019 May; 10(3):. PubMed ID: 31138748
    [No Abstract]   [Full Text] [Related]  

  • 30. Favorable Evolution of Cryptococcal Meningitis in the Context of Flucytosine Resistance.
    Claustre J; Brion JP; Quétant S; Bedouch P; Pison C; Camara B
    Exp Clin Transplant; 2018 Feb; 16(1):110-113. PubMed ID: 27143150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of an Ommaya reservoir in the management of children with cryptococcal meningitis.
    Jiang PF; Yu HM; Zhou BL; Gao F; Shen SX; Xia ZZ; Shui QX
    Clin Neurol Neurosurg; 2010 Feb; 112(2):157-9. PubMed ID: 19910108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
    Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of sequential treatment with amphotericin B-fluorocytosine and fluconazole in cryptococcal meningitis not associated with AIDS].
    Pintado García V; Martín Dávila P; Muñoz Labián V; Quereda Rodríguez-Navarro C
    Rev Clin Esp; 1999 Jul; 199(7):480. PubMed ID: 10481571
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
    Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN
    Elife; 2021 Sep; 10():. PubMed ID: 34581270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
    Perfect JR; Cox GM; Dodge RK; Schell WA
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluconazole and amphotericin B for cryptococcal meningitis.
    Clark AB; Lobo BL; Gelfand MS
    Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cryptococcal meningitis].
    van Spil WE; Nooijen S; de Jong PY; Aliredjo RP; de Sévaux RG; Verhave JC
    Ned Tijdschr Geneeskd; 2015; 159():A8478. PubMed ID: 25827149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in managing HIV-associated cryptococcal meningitis.
    Boyer-Chammard T; Temfack E; Alanio A; Jarvis JN; Harrison TS; Lortholary O
    F1000Res; 2019; 8():. PubMed ID: 31275560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.